The investigators' long-term objective is to make possible primary prevention of non-Hodgkin's lymphoma (NHL), an increasingly common and often fatal cancer with an etiology that is incompletely known.
The specific aim i s to investigate, through a broad interdisciplinary collaboration, the etiologic role of factors that entail immune modulation. The study will be large enough to allow analyses of these factors separately for several distinct subgroups, such as B-cell NHL, T-cell NHL, nodal/extranodal disease and chronic lymphocytic leukemia (CLL). Conditions and exposures to be characterized in detail include: Type-1 allergy, pattern and postponement of infection during childhood, chronic infections, autoimmune diseases, UV-light exposure, vaccinations, drugs that affect the immune system, and - notably for T-cell lymphomas - exposure to EBV and other viruses. Drawing on experience from nationwide collaborative studies between the major research centers in Denmark and Sweden, they propose to conduct a large, nationwide, population-based case-control study. A separate network for rapid case ascertainment will be set up to identify all individuals aged 15-74 years with a newly diagnosed, morphologically confirmed, and histopathologically uniformly classified NHL or CLL. Population controls, frequency-matched to the cases by sex, age, and country, will be regularly selected from population registers. Following informed consent, a blood sample will be obtained from all participants and a telephone interview will be carried out by means of a structured questionnaire. Self-reported information will be extensively completed and validated through linkages to national databases. They anticipate an 80 percent or higher participation rate. During a two-year period (two and a half years for T-cell NHL), they expect to include at least 2,000 patients with B-cell NHL, 400 patients with T-cell NHL, 525 patients with CLL, and approximately 3,000 population controls. The investigators state that the large size enables them to detect, with 80% power at a 5% level, factors that increase NHL by a factor of 1.3 or more for B-cell NHLs, 1.5 or more for T-cell NHLs, and 1.5 or more for CLL at an exposure prevalence of the risk factor in the general population of 1.5%. Major subgroups within B-cell NHL can be analyzed with similar statistical precision. The investigators state that the efficiency of the existing infrastructure, the ready access to nationwide population-based databases, the extensive previous experience with high participation rates, willingness to provide blood samples, and ready access to histopathological specimens provide a unique and effective platform in Scandinavia for such a large and comprehensive study.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA069269-03
Application #
6172826
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Patel, Appasaheb1 R
Project Start
1998-09-30
Project End
2003-08-31
Budget Start
2000-09-01
Budget End
2003-08-31
Support Year
3
Fiscal Year
2000
Total Cost
$644,289
Indirect Cost
Name
Statens Serum Institute
Department
Type
DUNS #
City
Copenhagen
State
Country
Denmark
Zip Code
Hollander, Peter; Rostgaard, Klaus; Smedby, Karin E et al. (2015) Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma. Am J Epidemiol 182:624-32
Cozen, W; Timofeeva, M N; Li, D et al. (2014) A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus. Nat Commun 5:3856
Kamper-Jørgensen, M; Rostgaard, K; Glaser, S L et al. (2013) Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph). Ann Oncol 24:2245-55
Gibson, Todd M; Smedby, Karin E; Skibola, Christine F et al. (2013) Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium. Cancer Causes Control 24:125-34
Foo, Jia Nee; Smedby, Karin E; Akers, Nicholas K et al. (2013) Coding variants at hexa-allelic amino acid 13 of HLA-DRB1 explain independent SNP associations with follicular lymphoma risk. Am J Hum Genet 93:167-72
Becker, Nikolaus; Falster, Michael O; Vajdic, Claire M et al. (2012) Self-reported history of infections and the risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Int J Cancer 131:2342-8
Skibola, Christine F; Conde, Lucia; Foo, Jia-Nee et al. (2012) A meta-analysis of genome-wide association studies of follicular lymphoma. BMC Genomics 13:516
Glimelius, Ingrid; Rubin, Jenny; Rostgaard, Klaus et al. (2011) Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin's lymphoma--a population-based study. Eur J Haematol 87:208-16
Grulich, Andrew E; Vajdic, Claire M; Falster, Michael O et al. (2010) Birth order and risk of non-hodgkin lymphoma--true association or bias? Am J Epidemiol 172:621-30
Vajdic, Claire M; Falster, Michael O; de Sanjose, Silvia et al. (2009) Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res 69:6482-9

Showing the most recent 10 out of 32 publications